Rédaction Africa Links 24 with Sade Oguntola
Published on 2024-03-07 05:20:55
The Chief Medical Director (CMD) of University College Hospital (UCH) in Ibadan, Professor Jesse Otegbayo, addressed the recent allegation that a patient purchased fake thyroid treatment drugs from the hospital. The complaint was brought to light on Instagram by a user with the handle @ThetundeT, but Otegbayo mentioned that the lack of specific details in the complaint makes it difficult for the hospital to investigate.
On February 18, @ThetundeT posted on Instagram stating that the drugs purchased for his wife’s thyroid treatment turned out to be fake after two years of treatment. He claimed they had been buying the medication from the UCH Pharmacy and expressed frustration with the situation. However, Otegbayo emphasized the need for more information such as the name of the drug, prescription details, and confirmation of the fake drug by regulatory authorities like NAFDAC.
Colonel Segun Ajanaku (retd), the Chairman of the Pharmaceutical Society of Nigeria in Oyo State, explained that fake pharmaceutical products are a global issue, and even genuine importers can unknowingly distribute counterfeit drugs. He highlighted the importance of traceability in the drug distribution process to prevent the influx of fake products. Ajanaku also emphasized the patient’s role in reporting the efficacy of the medication to their healthcare providers.
Additionally, a medical expert advised the patient to consult with her doctor before assuming the medication is fake. Thyroid disorders often require long-term treatment, and it is crucial for patients to communicate honestly with their healthcare providers about the effectiveness of their medication. Misleading information on social media can have detrimental effects on public health, especially if patients stop taking their prescribed medication without proper guidance.
The issue of counterfeit drugs requires a multi-dimensional approach to be resolved effectively. Patients should actively participate in their treatment by communicating openly with their healthcare providers and following up on the effects of their medication. It is essential to address concerns about medication efficacy with medical professionals rather than relying on social media for diagnosis and treatment advice.
In conclusion, the UCH is willing to engage with @ThetundeT to gather more information for a thorough investigation. The collaboration between patients, healthcare providers, and regulatory agencies is crucial in combating the distribution of fake and counterfeit drugs. Patients should take an active role in their healthcare by reporting any concerns or adverse reactions to their prescribed medication. Ultimately, addressing the issue of fake drugs requires a collective effort from all stakeholders involved in the healthcare system.
Read the original article on Nigerian Tribune
